Previous Close | 2.1500 |
Open | 1.5400 |
Bid | 1.3900 |
Ask | 1.6800 |
Strike | 130.00 |
Expire Date | 2024-05-10 |
Day's Range | 0.8100 - 2.5300 |
Contract Range | N/A |
Volume | |
Open Interest | 989 |
Moderna ( NASDAQ:MRNA ) First Quarter 2024 Results Key Financial Results Revenue: US$167.0m (down 91% from 1Q 2023...
Despite a significant revenue drop, Moderna showcases robust clinical progress and strategic collaborations.
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.